Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05539976 · ClinicalTrials.gov registry record
A Taste Assessment of Iberdomide and Mezigdomide in Healthy Participants
A clinical trial of Healthy Participants, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT05539976: Completed study of Healthy Participants, sponsored by Bristol-Myers Squibb.
NCT05539976 is a study of Healthy Participants that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 10 participants, below the 66-participant average among 119 other Healthy Participants trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05539976, a study of Healthy Participants, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop taste profiles of iberdomide and mezigdomide drug substances and oral formulation prototypes in order to develop a pediatric oral form of iberdomide and mezigdomide.
Conditions Studied
Study Locations (1)
Massachusetts
- Local Institution - 0001 - Woburn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-09-30 |
| Est. Completion | 2022-11-14 |
What the finished NCT05539976 record still lists
NCT05539976 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 66-participant average among 119 other Healthy Participants trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Healthy Participants appearing as the primary indexed condition, and to 0 interventions.
NCT05539976 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05539976 about?
NCT05539976 is a clinical study titled "A Taste Assessment of Iberdomide and Mezigdomide in Healthy Participants". The purpose of this study is to develop taste profiles of iberdomide and mezigdomide drug substances and oral formulation prototypes in order to develop a pediatric oral form of iberdomide and mezigdomide.
What is the current status of trial NCT05539976?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2022-09-30. Estimated completion is 2022-11-14.
What conditions does trial NCT05539976 study?
This clinical trial studies the following conditions: Healthy Participants.
Who is sponsoring clinical trial NCT05539976?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05539976 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Participants
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05539976's enrollment target sits among peer trials
10 115th of 119 higher than 4 of 119 other Healthy Participants trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Participants trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male Participants
RECRUITING · Phase 1
-
Impact of Exogenous Ketones on Sleep and Breathing in Healthy Volunteers (K-SLEEP)
RECRUITING · Phase 1
-
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
RECRUITING · NA
-
A Study to Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without Food
RECRUITING · Phase 1
-
A Food Effect Study to Evaluate the Relative Bioavailability of Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants
RECRUITING · Phase 1
-
Fructose Intestinal Gluconeogenesis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI